Hyperandrogenemia and Altered Day-night LH Pulse Patterns

NCT03068910 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Hyperandrogenism
Polycystic Ovary Syndrome
Puberty

Interventions

DRUG: Micronized progesterone
DRUG: Spironolactone
DRUG: Placebo

Sponsor

University of Virginia

Collaborators

[object Object]